Zhong Xin Jia

TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China.

Xuanzhu Biopharmaceutical Co., Ltd. engages in the research and development of chemical and biological drugs. Its products include small molecular chemical drugs, monoclonal antibodies, bispecific antibodies, and antibody conjugated drugs. The company was founded in 2002 and is headquartered in Shijiazhuang, China.

Part of Sinopharm Industrial Investment Co., Ltd., Shenzhen Pharmaceutical Factory engages in pharmaceuticals production. The company is based in Shenzhen, China. Shenzhen Pharmaceutical Factory was acquired by China National Accord Medicines Corp. Ltd. from Shenzhen City Investment Management Co. Ltd. on October 20, 2001 for $3.27 million.